Views & Analysis Could the PPRS support a changing growth and innovation agen... Has the PPRS delivered on the aim to support the government’s growth and innovation agenda?
Views & Analysis Frontiers Health 2017 Live Blog - Day One coverage The pharmaphorum team were on site and reporting live with all the key learnings and insights from Frontiers Health 2017.
Views & Analysis Exclusive live coverage: Frontiers Health 2017 What does the cutting-edge of digital health look like? Which innovations are on the cusp of becoming a mainstream reality and who is it that is driving this advancement?
Views & Analysis Nanomedicine: delivering on its promise? The nanomedicines market is worth billions. Tarun Pandotra reviews developments in the sector.
Partner Content Partner Content How Doctors’ Conversations Differ From Private to Public Soc... ocial Media in Pharma
Views & Analysis Keep it simple, scientists: AZ’s productivity push regains 1... AZ time management challenge has saved more than two million hours across the global company.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
